WHY DO PATIENTS WITH MANIC-DEPRESSIVE ILLNESS STOP THEIR LITHIUM. = POURQUOI LES MALADES SOUFFRANT DE MALADIE MANIACO-DEPRESSIVE ARRETENT-T-ILS LEUR LITHIUM.VAN PUTTEN T.1975; COMPREHENS. PSYCHIATRY; U.S.A.; DA. 1975; VOL. 16; NO 2; PP. 179-183; BIBL. 16 REF.Article

DRUG REFUSAL IN SCHIZOPHRENIA: CAUSES AND PRESCRIBING HINTS.VAN PUTTEN T.1978; HOSP. COMMUN. PSYCHIATRY; U.S.A.; DA. 1978; VOL. 29; NO 2; PP. 110-112; BIBL. 11 REF.Article

LITHIUM-INDUCED DISABLING TREMOR.VAN PUTTEN T.1978; PSYCHOSOMATICS; USA; DA. 1978; VOL. 19; NO 1; PP. 27-31 (2P.); BIBL. 8 REF.Article

FLUPHENAZINE ENANTHATE INDUCED DECOMPENSATIONSVAN PUTTEN T; MUTALIPASSI LR.1975; PSYCHOMATICS; U.S.A.; DA. 1975; VOL. 16; NO 1; PP. 37-40; BIBL. 20 REF.Article

LITHIUM IN TREATMENT FAILURES. = LITHIUM DANS LES ECHECS THERAPEUTIQUESVAN PUTTEN T; SANDERS DG.1975; J. NERV. MENTAL DIS.; U.S.A.; DA. 1975; VOL. 161; NO 4; PP. 255-264; BIBL. 27 REF.Article

"AKINETIC DEPRESSION" IN SCHIZOPHRENIAVAN PUTTEN T; MAY PRA.1978; ARCH. GEN. PSYCHIATRY; USA; DA. 1978; VOL. 35; NO 9; PP. 1101-1107; BIBL. 48 REF.Article

LITHIUM CARBONATE IN PERSONALITY DISORDERS: A CASE OF HYSTERIA.VAN PUTTEN T; ALBAN J.1977; J. NERV. MENTAL DIS.; U.S.A.; DA. 1977; VOL. 164; NO 3; PP. 218-222; BIBL. 30 REF.Article

DOES A PLASMA LEVEL OF CHLORPROMAZINE HELP.VAN PUTTEN T; MAY PRA; JENDEN DJ et al.1981; PSYCHOL. MED.; ISSN 0033-2917; GBR; DA. 1981; VOL. 11; NO 4; PP. 729-734; BIBL. 20 REF.Article

PHENOTHIAZINE-INDUCED DECOMPENSATIONVAN PUTTEN T; MUTALIPASSI LR; MALKIN MD et al.1974; ARCH. GEN. PSYCHIATRY; U.S.A.; DA. 1974; VOL. 30; NO 1; PP. 102-105; BIBL. 26REF.Article

SUBJECTIVE RESPONSE TO ANTIPSYCHOTIC DRUGSVAN PUTTEN T; MAY PRA; MARDER SR et al.1981; ARCH. GEN. PSYCHIATRY; ISSN 0003-990X; USA; DA. 1981; VOL. 38; NO 2; PP. 187-190; BIBL. 17 REF.Article

FAILURES ON A THERAPEUTIC MILIEU = ECHECS D'UN MILIEU THERAPEUTIQUEPARDES H; VAN PUTTEN T; BJORK D et al.1972; PSYCHIATR. QUART.; U.S.A.; DA. 1972; VOL. 46; NO 1; PP. 29-48; BIBL. 19REF.Article

PROGNOSIS IN SCHIZOPHRENIA: INDIVIDUAL DIFFERENCES IN PSYCHOLOGICAL RESPONSE TO A TEST DOSE OF ANTIPSYCHOTIC DRUG AND THEIR RELATIONSHIP TO BLOOD AND SALIVA LEVELS AND TREATMENT OUTCOMEMAY PRA; VAN PUTTEN T; JENDEN DJ et al.1981; COMPR. PSYCHIATRY; ISSN 0010-440X; USA; DA. 1981; VOL. 22; NO 2; PP. 147-152; BIBL. 17 REF.Article

Serum prolactin as a correlate of clinical response to haloperidolVAN PUTTEN, T; MARDER, S. R; MINTZ, J et al.Journal of clinical psychopharmacology. 1991, Vol 11, Num 6, pp 357-361, issn 0271-0749Article

Propranolol as a primary treatment of neuroleptic-induced akathisiaIRWIN, M; SULLIVAN, G; VAN PUTTEN, T et al.The Hillside journal of clinical psychiatry. 1988, Vol 10, Num 2, pp 244-250, issn 0193-5216Article

Determination of plasma homovanillic acid by column liquid chromatography with electrochemical detectionARAVAGIRI, M; MARDER, S. R; VAN PUTTEN, T et al.Journal of chromatography. Biomedical applications. 1990, Vol 525, Num 2, pp 419-425, issn 0378-4347Article

PLASMA AND SALIVA LEVELS OF CHLORPROMAZINE AND SUBJECTIVE RESPONSEVAN PUTTEN T; MAY PRA; JENDEN DJ et al.1980; AM. J. PSYCHIATRY; ISSN 0002-953X; USA; DA. 1980; VOL. 137; NO 10; PP. 1241-1242; BIBL. 9 REF.Article

A controlled dose comparison of haloperidol in newly admitted schizophrenic patientsVAN PUTTEN, T; MARDER, S. R; MINTZ, J et al.Archives of general psychiatry. 1990, Vol 47, Num 8, pp 754-758, issn 0003-990X, 5 p.Article

Response to antipsychotic medication: the doctoŕs and the consumeŕs viewVAN PUTTEN, T; MAY, P. R. A; MARDER, S. R et al.The American journal of psychiatry. 1984, Vol 141, Num 1, pp 16-19, issn 0002-953XArticle

Information processing and neuroleptic response in acute and stabilized schizophrenic patientsMARDER, S. R; ASARNOW, R. F; VAN PUTTEN, T et al.Psychiatry research. 1984, Vol 13, Num 1, pp 41-49, issn 0165-1781Article

Akathisia with haloperidol and thiothixeneVAN PUTTEN, T; MAY, P. R. A; MARDER, S. R et al.Archives of general psychiatry. 1984, Vol 41, Num 11, pp 1036-1039, issn 0003-990XArticle

Pharmacokinetics of long-acting injectable neuroleptic drugs: clinical implicationsMARDER, S. R; HUBBARD, J. W; VAN PUTTEN, T et al.Psychopharmacologia. 1989, Vol 98, Num 4, pp 433-439, issn 0033-3158Article

A study of medication refusal by involuntary psychiatric patientsMARDER, S. R; SWANN, E; WINSLADE, W. J et al.Hospital & community psychiatry. 1984, Vol 15, Num 7, pp 724-726, issn 0022-1597Article

Low- and conventional-dose maintenance therapy with fluphenazine decanoateMARDER, S. R; VAN PUTTEN, T; MINTZ, J et al.Archives of general psychiatry. 1987, Vol 44, Num 6, pp 518-521, issn 0003-990XArticle

Clinical perspectives of some neuroleptics through development and application of their assaysMIDHA, K. K; MARDER, S. R; JAWORSKI, T. J et al.Therapeutic drug monitoring. 1993, Vol 15, Num 3, pp 179-189, issn 0163-4356Conference Paper

Fluphenazine plasma levels in patients receiving low and conventional doses of fluphenazine decanoateMARDER, S. R; HAWES, E. M; VAN PUTTEN, T et al.Psychopharmacologia. 1986, Vol 88, Num 4, pp 480-483, issn 0033-3158Article